You Connected With a Global Community of Experts
In today’s competitive and unpredictable allogeneic cell therapy landscape, a strong donor screening strategy creates a true competitive edge. To support this, biotech and pharma companies are in search of solution providers they can trust to provide excellent account management and reliable, high-quality services.
From our market research, leading industry experts in the field have mentioned they need help from service providers and require meaningful partnerships to aid with characterization testing, donor recruitment and management, viral testing, provide high quality leukopaks and apheresis services and more!
Why Become a Partner in 2026?
Showcase Your Leadership
In donor screening and variability for allogeneic therapies by engaging with a focused audience of decision-makers from pharma, biotech, and academia
Drive Partnerships
And build your reputation as a go-to collaborator in shaping the future of allogeneic cell therapies
Stand Out from the Competition
By aligning your brand with the only conference dedicated to tackling donor variability with cutting-edge science and practical solutions
Audience Composition
Company Type
Attendee Seniority
Attending Companies Included
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.